Bad things happen when our patients go into the ICU and it's not always due to the disease. Good things happen when we rise from sitting. And guess what? Rheumatologists are setting cardiology straight about hydroxychloroquine and chloroquine. This, and a special recognition of parent-child rheumatologists, along with the news and articles from this week on RheumNow.
Dr. John Cush RheumNow
4 years 11 months ago
MMWR reports those who have recv COVID-19 vaccine have lower risk non–COVID-19 mortality (vs unvaccinated). Adjusted rel risk of non–COVID-19 death for Pfizer-vaccine (2 doses RR 0.34), Moderna (0.31), Janssen (0.54). NO INCR MORTAL RISK IN VACCINATED https://t.co/X6X1w1aYoU
TheDaoIndex KDAO2011
4 years 11 months ago
"ECG monitoring is not part of the current standard practice when HCQ or CQ is prescribed for...rheumatologic or dermatologic conditions."
-pub 10/26/21 ACR White Paper on Antimalarial Cardiac Toxicity https://t.co/uBqm5LBsob
Dr. John Cush RheumNow
4 years 11 months ago
Health insurance data from Korea analyzed 17,854 SLE pts & saw incr risk hematologic & solid cancers; solid (126.9/10K PY;SIR 1.8), heme (11.2/10KPYs; SIR 1.7). Most common in SLE: breast, reproductive & thyroid then liver & colon cancers https://t.co/dRs7SUwUAY
Dr. John Cush RheumNow
4 years 11 months ago
ACR publishes a "White paper on Antimalarial Cardiac Toxicity"- reviewing drug hx, indications, effects and rare risk of arrhythmias, conduction abnormalities, cardiomyopathy, QTc prolongation. torsade de pointes. No evidence for routine ECG monitoring https://t.co/2aemSKzk3T https://t.co/3stH4TntBT
Dr. John Cush RheumNow
4 years 11 months ago
The Sacroiliac Joint - some call this a symphysis, but it is an "amphiarthrosis", or sliding joint, with minimal movement; Only the lower (distal) 1/3 of the joint is synovial lined -- this is where one should look for sacroiliitis. https://t.co/8uD13h2qHZ https://t.co/D3UERVXrgX https://t.co/3E3N1FnqDY
Dr. John Cush RheumNow
4 years 11 months ago
FDA put a box warnings on breast implant packaging to include info that 1)Breast implants are not lifetime devices; 2) complication risk increases over time; 3) risk of anaplastic large cell lymphoma, 4) may be assoc w/ systemic Sxs https://t.co/VnpJg45PZY
National Health Data from France examined biologic use in patients with moderate to severe psoriasis, and found the risk of serious infections (SIE) to be increased with some biologics (infliximab and adalimumab), but not others (etanercept, ustekinumab IL-17 and IL-23 inhibitors or apremilast).
Dr. John Cush RheumNow
4 years 11 months ago
Rheumatoid Arthritis Thrombotic Risk Influenced by DMARD Choice
https://t.co/gOLhO2aNOo https://t.co/FwKP3slExA
Dr. John Cush RheumNow
4 years 11 months ago
QD Clinic - The Thyroid Lump
QD Clinic is sponsored by https://t.co/V10S4oE43V's coverage of #ACR21
https://t.co/J5YkJmaNea https://t.co/UidG4dT1JJ
Dr. John Cush RheumNow
4 years 11 months ago
Platelet-Rich Plasma Injections Fail in Ankle Osteoarthritis
https://t.co/Fmf8f2C3Y4 https://t.co/9ZJe2jAYVw
Dr. John Cush RheumNow
4 years 11 months ago
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow
https://t.co/riyAnrRHhX https://t.co/MkoDsw34D0
The Annals of Internal Medicine reports that targeting B-cells in refractory systemic lupus erythematosus (SLE) with sequential belimumab after rituximab may significantly reduce dsDNA antibody titers and lessen the number of future severe flares.
Dr. John Cush RheumNow
4 years 11 months ago
While psoriasis and Psoriatic arthritis patients have an increased risk of fractures, there is no increased risk of osteoporosis or osteopenia. Data from 12 studies an 199 million individuals https://t.co/G4Ya7CUWYX
